Tuhura Biosciences holds annual shareholder meeting

• Tuhura Biosciences held its annual shareholder meeting on Aug. 18, 2026.
• Shareholders backed a plan to issue 1,878,287 common shares under a fee letter; the share issuance was authorized, not yet completed.
• Investors selected a three-year interval for future advisory votes on executive pay.
• Cherry Bekaert was ratified as independent auditor for the fiscal year ending Dec. 31, 2026.
• An adjournment authorization passed, though the meeting was not adjourned.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tuhura Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-357087), on August 19, 2026, and is solely responsible for the information contained therein.